2019
Higher Inpatient Mortality for Women after Intervention for Lifestyle Limiting Claudication
Miller SM, Sumpio BJ, Miller MS, Erben Y, Cordova AC, Sumpio BE. Higher Inpatient Mortality for Women after Intervention for Lifestyle Limiting Claudication. Annals Of Vascular Surgery 2019, 58: 54-62. PMID: 30910650, DOI: 10.1016/j.avsg.2019.01.006.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsAgedComorbidityCritical IllnessDatabases, FactualEndovascular ProceduresFemaleHealth Status DisparitiesHospital MortalityHumansIntermittent ClaudicationIschemiaMalePatient AdmissionPeripheral Arterial DiseaseRisk AssessmentRisk FactorsSex FactorsTime FactorsTreatment OutcomeUnited StatesVascular Surgical ProceduresConceptsLifestyle-limiting claudicationHigher inpatient mortalityCritical limb ischemiaPeripheral artery diseaseInpatient mortalitySex-related differencesVascular interventionsEV interventionsArtery diseaseChronic obstructive pulmonary diseaseRegression analysisChronic renal failureObstructive pulmonary diseaseOpen surgical repairCoronary artery diseaseNationwide Inpatient SampleLogistic regression analysisChi-squared testLimb ischemiaRenal failureIndependent predictorsOpen repairPulmonary diseaseSurgical repairTreatment guidelines
1985
Reduction of the drug-induced nephrotoxicity by ATP-MgCl2. 1. Effects on the cis-Diamminedichloroplatinum-treated isolated perfused kidneys
Sumpio B, Chaudry I, Baue A. Reduction of the drug-induced nephrotoxicity by ATP-MgCl2. 1. Effects on the cis-Diamminedichloroplatinum-treated isolated perfused kidneys. Journal Of Surgical Research 1985, 38: 429-437. PMID: 3872963, DOI: 10.1016/0022-4804(85)90058-7.Peer-Reviewed Original ResearchConceptsAcute renal failureATP-MgCl2Hr of perfusionCis-DiamminedichloroplatinumNephrotoxic effectsReabsorptive capacityCDDP treatmentRat kidneyATP-MgCl2 treatmentIsolated rat kidneyDrug-induced nephrotoxicityDirect nephrotoxic effectNew therapeutic modalitiesProximal tubule cellsCancer chemotherapeutic agentsCDDP therapyRenal failureMarked diuresisProtein reabsorptionTherapeutic modalitiesTubule cellsChemotherapeutic agentsMicrograms/KidneyMarked inhibition